Registry of transcatheter aortic-valve implantation in high-risk patients

M. Gilard*, H. Eltchaninoff, B. Iung, K. Chevreul, J. Fajadet, P. Leprince, A. Leguerrier, M. Lievre, A. Prat, E. Teiger, T. Lefevre, D. Himbert, D. Tchetche, D. Carriè, B. Albat, A. Cribier, G. Rioufol, A. Sudre, D. Blanchard, F. ColletP. Dos Santos, N. Meneveau, A. Tirouvanziam, C. Caussin, P. Guyon, J. Boschat, H. Le Breton, F. Collart, R. Houel, S. Delpine, G. Souteyrand, X. Favereau, P. Ohlmann, V. Doisy, G. Grollier, A. Gommeaux, Massimo Massetti

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

978 Citazioni (Scopus)

Abstract

Transcatheter aortic-valve implantation (TAVI) is an emerging intervention for the treatment of high-risk patients with severe aortic stenosis and coexisting illnesses. We report the results of a prospective multicenter study of the French national transcatheter aortic-valve implantation registry, FRANCE 2.
Lingua originaleInglese
pagine (da-a)1705-1715
Numero di pagine11
RivistaNew England Journal of Medicine
Volume366
Numero di pubblicazione18
DOI
Stato di pubblicazionePubblicato - 2012

All Science Journal Classification (ASJC) codes

  • Medicina Generale

Keywords

  • 80 and over
  • Aged
  • Aortic Valve Stenosis
  • Cardiac Catheterization
  • Female
  • France
  • Heart Valve Prosthesis
  • Heart Valve Prosthesis Implantation
  • Hemorrhage
  • Humans
  • Incidence
  • Male
  • Multivariate Analysis
  • Prospective Studies
  • Registries
  • Stroke

Fingerprint

Entra nei temi di ricerca di 'Registry of transcatheter aortic-valve implantation in high-risk patients'. Insieme formano una fingerprint unica.

Cita questo